AAOI
Applied Optoelectronics, Inc.
AAOI lost money over the past year, so it has no meaningful PE right now. Analysts expect earnings to recover and profitability to improve, though they disagree widely on how much.
MRT
Marti Technologies, Inc.
There isn't enough reported data to score MRT yet.
AAOI Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| Weak | |
| Unavailable |
AAOI's revenue is currently strong, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
MRT Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Under pressure | |
| Unavailable | |
| Unavailable |
MRT's profitability is currently under pressure. There isn't enough data to rate its revenue, cash flow and balance sheet.
AAOI PE Valuation
AAOI has no meaningful PE right now: it lost money over the past year. If it returns to profit as analysts expect, today's price would be 18x next year's earnings.
MRT PE Valuation
MRT has no meaningful PE right now: it lost money over the past year. If it returns to profit as analysts expect, today's price would be 154x next year's earnings.
AAOI Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect AAOI to return to profit, with revenue growing. However, they disagree widely on these estimates.
MRT Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect MRT to return to profit, with revenue growing.
AAOI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.98 | โ |
| Q3 2026 | -$0.42 | +$3.02 |
| Q2 2026 | -$0.77 | +$2.81 |
| Q1 2026 | -$0.65 | +$3.43 |
| Q4 2025 | -$0.64 | +$3.86 |
| Q3 2025 | -$3.44 | -$1.41 |
| Q2 2025 | -$3.58 | -$1.70 |
| Q1 2025 | -$4.08 | -$2.29 |
| Q4 2024 | -$4.50 | -$2.75 |
AAOI has the stronger earnings trend. Trailing diluted EPS is down 112% for AAOI versus MRT down 130%.
MRT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.01 | โ |
| Q3 2026 | -$0.37 | +$0.47 |
| Q4 2025 | -$0.52 | +$0.76 |
| Q3 2025 | -$0.84 | +$0.15 |
| Q2 2025 | -$1.16 | -$0.72 |
| Q1 2025 | -$1.22 | -$0.78 |
| Q4 2024 | -$1.28 | -$0.84 |
| Q3 2024 | -$0.99 | -$0.55 |
| Q2 2024 | -$0.44 | +$0.14 |
MRT is still losing money, but far less than before: $0.37 per share over the past year, against $1.28 at its worst in late 2024.
AAOI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $269.9M | +127% |
| Q2 2026 | $191.9M | +86% |
| Q1 2026 | $151.1M | +51% |
| Q4 2025 | $134.3M | +34% |
| Q3 2025 | $118.6M | +82% |
| Q2 2025 | $103M | +138% |
| Q1 2025 | $99.9M | +146% |
| Q4 2024 | $100.3M | +66% |
MRT has the stronger quarterly revenue trend. Revenue is up 127% for AAOI versus up 740% for MRT.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -0.5% | +15 points |
| Q2 2026 | -13% | +2.6 points |
| Q1 2026 | -8.6% | +0.3 points |
| Q4 2025 | -8.6% | -2.1 points |
| Q3 2025 | -15% | +10 points |
| Q2 2025 | -16% | +45 points |
| Q1 2025 | -8.9% | +44 points |
| Q4 2024 | -6.5% | +1 points |
AAOI has the edge over MRT on profitability, with a higher operating margin.
MRT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $60.1M | +383% |
| Q4 2025 | $12.5M | +143% |
| Q3 2025 | $12.5M | +143% |
| Q2 2025 | $7.2M | +70% |
| Q1 2025 | $7.2M | +70% |
| Q4 2024 | $5.1M | -50% |
| Q3 2024 | $5.1M | +1982% |
| Q2 2024 | $4.2M | -11% |
MRT's revenue has grown year over year for five quarters in a row: $60M last quarter, up 740% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -1.8% | +86 points |
| Q4 2025 | -64% | +395 points |
| Q3 2025 | -64% | +395 points |
| Q2 2025 | -88% | +129 points |
| Q1 2025 | -88% | +129 points |
| Q4 2024 | -459% | -224 points |
| Q3 2024 | -459% | -3597 points |
| Q2 2024 | -217% | -68 points |
MRT's operating margin was โ1.8% last quarter, up 86 points from the same quarter a year ago.
AAOI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$369.9M | -$291.2M |
| Q2 2026 | -$265.3M | -$174.4M |
| Q1 2026 | -$143.6M | -$64.3M |
| Q4 2025 | -$104.6M | -$51.6M |
| Q3 2025 | -$78.7M | -$58M |
| Q2 2025 | -$91M | -$86M |
| Q1 2025 | -$79.3M | -$45.1M |
| Q4 2024 | -$53M | -$48.4M |
MRT has the stronger cash trend. Its trailing FCF is up 11% versus its history, compared with AAOI at down 676%.
MRT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.8M | +$3.2M |
| Q4 2025 | -$5M | +$2.4M |
| Q3 2025 | -$5M | +$2.4M |
| Q2 2025 | -$2.6M | +$2.6M |
| Q1 2025 | -$2.6M | +$2.6M |
| Q4 2024 | -$7.4M | +$5.8M |
| Q3 2024 | -$7.4M | -$2.6M |
| Q2 2024 | -$5.3M | -$275.7K |
MRT has burned cash in almost every quarter: โ$14M over the past year, against โ$23M the year before.
AAOI Net Leverage
AAOI's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
MRT Net Leverage
MRT's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
AAOI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 35.1 | Neutral |
| Stochastic | 4.8 | Oversold |
AAOI's weekly RSI is 35 (neutral) and its Stochastic is 5 (oversold).
MRT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.5 | Neutral |
| Stochastic | 57.6 | Neutral |
MRT's weekly RSI is 52 (neutral) and its Stochastic is 58 (neutral).
AAOI PE vs Technology Sector
AAOI has no meaningful PE right now: it lost money over the past year.
MRT PE vs Technology Sector
MRT has no meaningful PE right now: it lost money over the past year.
AAOI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $80.2 | 34% below |
| 20 week MA | $100.6 | 47% below |
| 50 week MA | $100.3 | 47% below |
| 100 week MA | $62.3 | 15% below |
| 200 week MA | $36.9 | 43% above |
AAOI has fallen below most of its moving averages, though it's still 43% above its 200-week average.
MRT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.99 | 1.5% above |
| 20 week MA | $1.91 | 5.8% above |
| 50 week MA | $2.00 | 1% above |
| 100 week MA | $2.43 | 17% below |
| 200 week MA | $3.05 | 34% below |
MRT has the edge over AAOI on trend strength, trading above more of its moving averages.
AAOI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $11.5 | $8.77 | -24% |
| 2021 | $8.77 | $5.64 | -36% |
| 2022 | $5.64 | $1.95 | -65% |
| 2023 | $1.95 | $19.3 | +891% |
| 2024 | $19.3 | $37.7 | +95% |
| 2025 | $37.7 | $37.2 | -1.5% |
| 2026 YTD | $37.2 | $52.9 | +42% |
AAOI has the edge over MRT on returns for 2026, with the stronger performance.
MRT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $9.75 | $9.89 | +1.4% |
| 2022 | $9.89 | $10.2 | +3.1% |
| 2023 | $10.2 | $0.65 | -94% |
| 2024 | $0.65 | $3.39 | +422% |
| 2025 | $3.39 | $2.31 | -32% |
| 2026 YTD | $2.31 | $2.02 | -13% |
MRT's yearly returns have swung widely, from +422% in 2024 to โ94% in 2023. It's down 13% so far in 2026.